KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Gains from Sales and Divestitures (2016 - 2019)

Historic Gains from Sales and Divestitures for Exact Sciences (EXAS) over the last 10 years, with Q3 2019 value amounting to $3.8 million.

  • Exact Sciences' Gains from Sales and Divestitures rose 21487.61% to $3.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $3.8 million, marking a year-over-year increase of 21487.61%. This contributed to the annual value of $1.3 million for FY2018, which is 1284.7% up from last year.
  • Latest data reveals that Exact Sciences reported Gains from Sales and Divestitures of $3.8 million as of Q3 2019, which was up 21487.61% from $3.5 million recorded in Q2 2019.
  • In the past 5 years, Exact Sciences' Gains from Sales and Divestitures ranged from a high of $3.8 million in Q3 2019 and a low of $237061.0 during Q1 2015
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $839252.0 (2017), whereas its average is $1.2 million.
  • As far as peak fluctuations go, Exact Sciences' Gains from Sales and Divestitures surged by 1183.83% in 2018, and later skyrocketed by 28649.92% in 2019.
  • Quarter analysis of 5 years shows Exact Sciences' Gains from Sales and Divestitures stood at $578033.0 in 2015, then surged by 37.74% to $796168.0 in 2016, then surged by 42.21% to $1.1 million in 2017, then rose by 12.85% to $1.3 million in 2018, then skyrocketed by 198.09% to $3.8 million in 2019.
  • Its Gains from Sales and Divestitures was $3.8 million in Q3 2019, compared to $3.5 million in Q2 2019 and $3.4 million in Q1 2019.